EMA & FDA Hold Workshop to Study Drug-related PML
Some 170 experts and stakeholders discussed a common way forward for research in drug-related PML, including possibilities for funding and partnerships, and mechanisms for information sharing.
The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) recently held a two-day workshop in London on drug-related progressive multifocal leukoencepalopathy (PML). The meeting aimed to bring together experts and stakeholders of PML to identify research questions that will address knowledge gaps in order to reduce the burden of the disease.
Some 170 experts and stakeholders from regulatory authorities, research funding bodies, academic and clinical researchers, patients and healthcare representatives and industry discussed a common way forward for research in drug-related PML, including possibilities for funding and partnerships, and mechanisms for information sharing.
PML is a rare, debilitating and sometimes fatal d
Related News
-
News A Day in the Life of a Pharma Event Director
The Day in the Life of series has covered most of the pharmaceutical supply chain looking through the eyes of the people working in the different fields, from R&D to manufacturing. What we haven't seen yet, is the role that non-pharma companies can... -
News On Track at CPHI Milan: The RTU Alliance on the importance of packaging innovation
As CPHI Milan gets ever closer, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma, and the innovations that are set to shake up the industry. -
News CPHI Milan Speaker Spotlight: The microbiome and investing in future therapies
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conference. -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News Latest updates for semaglutide: reduction of renal failure risk
Recent data presented at the 2024 European Society for Cardiology (ESC) conference analysed Novo Nordisk’s Ozempic (semaglutide) and its effectiveness in the management of chronic kidney disease (CKD). This follows previous analysis on semaglutid... -
News CPHI Milan Speaker Spotlight: CDMO relations with Pharma and Start-Ups
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News What can you expect from CPHI Milan 2024?
CPHI Milan 2024 marks the 35th anniversary of CPHI. The 35th Edition of the show, taking place 8–10 October, promises to be a celebration of everything pharma, covering every sector, and featuring thought leaders and trailblazers shaking up the i...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance